Current and historical daily PE Ratio for HRMY (
Harmony Biosciences Holdings Inc
) from 2020 to May 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Harmony Biosciences stock (HRMY) PE ratio as of May 26 2024 is 12.97.
More Details
Harmony Biosciences Holdings Inc (HRMY) PE Ratio (TTM) Chart
Harmony Biosciences Holdings Inc (HRMY) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 949
- 1
- 2
- 3
- 4
- 5
- 6
- 11
| Harmony Biosciences PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-26 | 13.0 | 2024-03-22 | 15.7 |
| 2024-05-24 | 13.0 | 2024-03-21 | 15.8 |
| 2024-05-23 | 12.7 | 2024-03-20 | 15.9 |
| 2024-05-22 | 13.1 | 2024-03-19 | 15.3 |
| 2024-05-21 | 12.8 | 2024-03-18 | 14.9 |
| 2024-05-20 | 12.9 | 2024-03-15 | 15.1 |
| 2024-05-17 | 12.6 | 2024-03-14 | 14.8 |
| 2024-05-16 | 12.7 | 2024-03-13 | 14.1 |
| 2024-05-15 | 12.9 | 2024-03-12 | 14.3 |
| 2024-05-14 | 12.9 | 2024-03-11 | 14.5 |
| 2024-05-13 | 13.1 | 2024-03-08 | 14.7 |
| 2024-05-10 | 13.1 | 2024-03-07 | 14.6 |
| 2024-05-09 | 13.5 | 2024-03-06 | 14.5 |
| 2024-05-08 | 13.7 | 2024-03-05 | 14.5 |
| 2024-05-07 | 13.6 | 2024-03-04 | 14.6 |
| 2024-05-06 | 13.4 | 2024-03-01 | 15.2 |
| 2024-05-03 | 13.7 | 2024-02-29 | 15.1 |
| 2024-05-02 | 13.7 | 2024-02-28 | 15.7 |
| 2024-05-01 | 13.1 | 2024-02-27 | 15.8 |
| 2024-04-30 | 13.4 | 2024-02-26 | 15.3 |
| 2024-04-29 | 12.7 | 2024-02-23 | 15.3 |
| 2024-04-26 | 12.7 | 2024-02-22 | 14.8 |
| 2024-04-25 | 12.5 | 2024-02-21 | 15.6 |
| 2024-04-24 | 12.7 | 2024-02-20 | 15.6 |
| 2024-04-23 | 12.5 | 2024-02-16 | 15.9 |
| 2024-04-22 | 12.7 | 2024-02-15 | 16.5 |
| 2024-04-19 | 12.7 | 2024-02-14 | 16.0 |
| 2024-04-18 | 12.6 | 2024-02-13 | 15.5 |
| 2024-04-17 | 12.6 | 2024-02-12 | 16.3 |
| 2024-04-16 | 12.9 | 2024-02-09 | 15.7 |
| 2024-04-15 | 12.8 | 2024-02-08 | 15.9 |
| 2024-04-12 | 12.8 | 2024-02-07 | 15.0 |
| 2024-04-11 | 13.5 | 2024-02-06 | 14.9 |
| 2024-04-10 | 12.7 | 2024-02-05 | 14.3 |
| 2024-04-09 | 13.4 | 2024-02-02 | 14.7 |
| 2024-04-08 | 12.9 | 2024-02-01 | 14.8 |
| 2024-04-05 | 13.3 | 2024-01-31 | 14.9 |
| 2024-04-04 | 13.5 | 2024-01-30 | 15.0 |
| 2024-04-03 | 13.7 | 2024-01-29 | 15.2 |
| 2024-04-02 | 14.2 | 2024-01-26 | 14.7 |
| 2024-04-01 | 14.3 | 2024-01-25 | 14.6 |
| 2024-03-28 | 14.5 | 2024-01-24 | 14.5 |
| 2024-03-27 | 15.8 | 2024-01-23 | 15.0 |
| 2024-03-26 | 15.1 | 2024-01-22 | 15.3 |
| 2024-03-25 | 15.4 | 2024-01-19 | 14.9 |
Harmony Biosciences Holdings Inc (HRMY) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Harmony Biosciences Holdings Inc
NAICS : 541714
SIC : 2834
ISIN : US4131971040
Share Class Description:
HRMY: Ordinary SharesDescription
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers